Circulating sphingosine-1-phosphate depletion is associated with endothelial activation and altered brain-endothelial S1P pathway expression in ischemic stroke.
Saved in:
| Title: | Circulating sphingosine-1-phosphate depletion is associated with endothelial activation and altered brain-endothelial S1P pathway expression in ischemic stroke. |
|---|---|
| Authors: | Porschen LT; Department of Experimental Medical Science, Lund University, Lund, 221 84, Sweden.; Wallenberg Centre for Molecular Medicine, Lund University, Lund, 221 84, Sweden.; Division of Physiology & Vascular Biology, Institute of Theoretical Medicine, Faculty of Medicine, University of Augsburg, Universitätsstr. 2, 86159, Augsburg, Germany., Matthes F; Department of Experimental Medical Science, Lund University, Lund, 221 84, Sweden.; Wallenberg Centre for Molecular Medicine, Lund University, Lund, 221 84, Sweden.; Division of Physiology & Vascular Biology, Institute of Theoretical Medicine, Faculty of Medicine, University of Augsburg, Universitätsstr. 2, 86159, Augsburg, Germany., Matuskova H; Department of Experimental Medical Science, Lund University, Lund, 221 84, Sweden.; Wallenberg Centre for Molecular Medicine, Lund University, Lund, 221 84, Sweden.; Department of Vascular Neurology, University Hospital Bonn, 53127, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), 53127, Bonn, Germany., Braadt L; Division of Physiology & Vascular Biology, Institute of Theoretical Medicine, Faculty of Medicine, University of Augsburg, Universitätsstr. 2, 86159, Augsburg, Germany.; Department of Neurology and Clinical Neurophysiology, University Hospital Augsburg, Augsburg, Germany., Petzold GC; Department of Vascular Neurology, University Hospital Bonn, 53127, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), 53127, Bonn, Germany., Lindgren AG; Department of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden.; Department of Neurology, Rehabilitation Medicine, Memory Disorders and Geriatrics, Skåne University Hospital, Lund, Sweden., Meissner A; Department of Experimental Medical Science, Lund University, Lund, 221 84, Sweden. anja.meissner@uni-a.de.; Wallenberg Centre for Molecular Medicine, Lund University, Lund, 221 84, Sweden. anja.meissner@uni-a.de.; Division of Physiology & Vascular Biology, Institute of Theoretical Medicine, Faculty of Medicine, University of Augsburg, Universitätsstr. 2, 86159, Augsburg, Germany. anja.meissner@uni-a.de. |
| Source: | Fluids and barriers of the CNS [Fluids Barriers CNS] 2026 Jun 12; Vol. 23 (1). Date of Electronic Publication: 2026 Jun 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Biomed Central Country of Publication: England NLM ID: 101553157 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-8118 (Electronic) Linking ISSN: 20458118 NLM ISO Abbreviation: Fluids Barriers CNS Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42277837 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Circulating sphingosine-1-phosphate depletion is associated with endothelial activation and altered brain-endothelial S1P pathway expression in ischemic stroke. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Porschen+LT%22">Porschen LT</searchLink>; Department of Experimental Medical Science, Lund University, Lund, 221 84, Sweden.; Wallenberg Centre for Molecular Medicine, Lund University, Lund, 221 84, Sweden.; Division of Physiology & Vascular Biology, Institute of Theoretical Medicine, Faculty of Medicine, University of Augsburg, Universitätsstr. 2, 86159, Augsburg, Germany.<br /><searchLink fieldCode="AU" term="%22Matthes+F%22">Matthes F</searchLink>; Department of Experimental Medical Science, Lund University, Lund, 221 84, Sweden.; Wallenberg Centre for Molecular Medicine, Lund University, Lund, 221 84, Sweden.; Division of Physiology & Vascular Biology, Institute of Theoretical Medicine, Faculty of Medicine, University of Augsburg, Universitätsstr. 2, 86159, Augsburg, Germany.<br /><searchLink fieldCode="AU" term="%22Matuskova+H%22">Matuskova H</searchLink>; Department of Experimental Medical Science, Lund University, Lund, 221 84, Sweden.; Wallenberg Centre for Molecular Medicine, Lund University, Lund, 221 84, Sweden.; Department of Vascular Neurology, University Hospital Bonn, 53127, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), 53127, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Braadt+L%22">Braadt L</searchLink>; Division of Physiology & Vascular Biology, Institute of Theoretical Medicine, Faculty of Medicine, University of Augsburg, Universitätsstr. 2, 86159, Augsburg, Germany.; Department of Neurology and Clinical Neurophysiology, University Hospital Augsburg, Augsburg, Germany.<br /><searchLink fieldCode="AU" term="%22Petzold+GC%22">Petzold GC</searchLink>; Department of Vascular Neurology, University Hospital Bonn, 53127, Bonn, Germany.; German Center for Neurodegenerative Diseases (DZNE), 53127, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Lindgren+AG%22">Lindgren AG</searchLink>; Department of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden.; Department of Neurology, Rehabilitation Medicine, Memory Disorders and Geriatrics, Skåne University Hospital, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Meissner+A%22">Meissner A</searchLink>; Department of Experimental Medical Science, Lund University, Lund, 221 84, Sweden. anja.meissner@uni-a.de.; Wallenberg Centre for Molecular Medicine, Lund University, Lund, 221 84, Sweden. anja.meissner@uni-a.de.; Division of Physiology & Vascular Biology, Institute of Theoretical Medicine, Faculty of Medicine, University of Augsburg, Universitätsstr. 2, 86159, Augsburg, Germany. anja.meissner@uni-a.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101553157%22">Fluids and barriers of the CNS</searchLink> [Fluids Barriers CNS] 2026 Jun 12; Vol. 23 (1). <i>Date of Electronic Publication: </i>2026 Jun 12. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Biomed+Central%22">Biomed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101553157 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-8118 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220458118%22">20458118 </searchLink><i>NLM ISO Abbreviation: </i>Fluids Barriers CNS <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42277837 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12987-026-00828-z Languages: – Code: eng Text: English Titles: – TitleFull: Circulating sphingosine-1-phosphate depletion is associated with endothelial activation and altered brain-endothelial S1P pathway expression in ischemic stroke. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Porschen LT – PersonEntity: Name: NameFull: Matthes F – PersonEntity: Name: NameFull: Matuskova H – PersonEntity: Name: NameFull: Braadt L – PersonEntity: Name: NameFull: Petzold GC – PersonEntity: Name: NameFull: Lindgren AG – PersonEntity: Name: NameFull: Meissner A IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 06 Text: 2026 Jun 12 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2045-8118 Numbering: – Type: volume Value: 23 – Type: issue Value: 1 Titles: – TitleFull: Fluids and barriers of the CNS Type: main |
| ResultId | 1 |
